News

NerBloc, a botulinum toxin type B neuromuscular-blocking agent, has been approved by the Japanese regulatory authority in 21 January 2011. NerBloc has showed improvement in TWSTRS (Toronto Western

BMP Sunstone stockholders will now receive $10 per share in cash for common stock shares they owned prior to the effective time of the merger. Beijing-based BMP Sunstone,

Martek is involved in the innovation, development, production and sale of high-value products from microbial sources which promote health and wellness through nutrition. The transaction is part of

Under the pact, Selcia has used its proprietary CEfrag technique and has identified new and weak affinity hits from Selcia’s Fragment Library. Selcia claims that its CEfrag technology

The new film-forming polymer equips formulators with the know-how to manufacture hair sprays with firm and lasting hold. The hair styles secured by the new dispersion spray retain

Chinese herbal medicine business is engaged in the research and development, production and distribution of Chinese herbal medicines in China and overseas Following the transaction, the Chinese Herbal

Edarbi is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone. Results from clinical studies revealed that

Ganetespib is a potent, synthetic, small-molecule inhibitor of heat shock protein 90 – a molecular chaperone required for the proper folding and activation of many cancer-promoting proteins. The

Quintiles will make a minority 10% investment of about $30m in setting up a manufacturing plant (which will contract-make medicines derived from living cells) in the Songdo district